LOU YAN,HOGG JOAN HEALTHER,LE KANG,MISCHKE STEVEN GREGORY,REMISZEWSKI STACY
申请号：
CL2015000333
公开号：
CL2015000333A1
申请日:
2015.02.11
申请国别(地区):
CL
年份:
2015
代理人:
摘要：
Disclosed are compounds of Formula (I) or pharmaceutically acceptable salts thereof, wherein R1, R2, R3, m, n and q are described in this application, and methods of using said compounds in the treatment of cancer.<；p>；49 COMPUESTOS DERIVADOS DE ESPECÍ；FICOS DERIVADOS DE ISOINDOLIN-1CARBOXAMIDA, 1,2,3,4-TETRAHIDROISOQUINOLIN-1-CARBOXAMIDA, 2,3-DIHIDRO-1H-ISOINDOL-1-CARBOXÍ；LICO, INHIBIDORES DE BIR2 YO BIR3； COMPOSICIÓ；N FARMACÉ；UTICA； Ú；TILES PARA EL TRATAMIENTO DEL CÁ；NCER.<；/p>；
